Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer

被引：16
|
作者：
Tomasini, Pascale [1 ,2 ]
Greillier, Laurent [1 ,2 ]
Boyer, Arnaud [1 ,2 ]
Jeanson, Arnaud [1 ,2 ]
Barlesi, Fabrice [1 ,2 ]
机构：
[1] Aix Marseille Univ, Multidisciplinary Oncol & Therapeut Innovat Dept, AP HM, Marseille, France
[2] Aix Marseille Univ UM105, Inserm UMR1068, CNRS UMR7258, Predict Oncol Lab,Ctr Rech Cancerol Marseille, Marseille, France
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
TREMELIMUMAB COMBINATION THERAPY; PLATINUM-BASED CHEMOTHERAPY; 1ST-LINE TREATMENT; PLUS TREMELIMUMAB; PATIENTS PTS; MEDI4736; PHASE-3; NSCLC; RADIOTHERAPY; MULTICENTER;
D O I：
10.21037/jtd.2018.04.61
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S1032 / S1036
页数：5
相关论文
共 50 条
  • [21] Prospective evaluation of outcome and toxicity of durvalumab treatment after chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC) patients
    Kaesmann, Lukas
    Taugner, Julian
    Eze, Chukwuka
    Roengvoraphoj, Olarn
    Belka, Claus
    Manapov, Farkhad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [22] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy
    Oh, H. -J.
    Park, C. -K.
    Kim, Y. -C.
    Kim, Y. -H.
    Ahn, S. -J.
    Jeong, W. G.
    Lee, J. Y.
    Lee, J. C.
    Choi, C. M.
    Ji, W.
    Song, S. Y.
    Choi, J.
    Lee, S. Y.
    Kim, H.
    Lee, S. Y.
    Park, J.
    Yoon, S. H.
    Joo, J. H.
    Oh, I. -J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S294 - S295
  • [23] Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer
    Kishi, Noriko
    Matsuo, Yukinori
    Shintani, Takashi
    Ogura, Masakazu
    Mitsuyoshi, Takamasa
    Araki, Norio
    Fujii, Kota
    Okumura, Setsuko
    Nakamatsu, Kiyoshi
    Kishi, Takahiro
    Atsuta, Tomoko
    Sakamoto, Takashi
    Ohtsu, Shuji
    Katagiri, Tomohiro
    Narabayashi, Masaru
    Fujishiro, Satsuki
    Iizuka, Yusuke
    Ozasa, Hiroaki
    Hirai, Toyohiro
    Mizowaki, Takashi
    JOURNAL OF RADIATION RESEARCH, 2023, 64 (01) : 142 - 153
  • [24] Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report
    Zhang, Tao
    Wu, Yuqi
    Zheng, Shan
    Cheng, Guowei
    He, Xiangling
    Bi, Nan
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (04) : 2375 - 2380
  • [25] The impact of dosimetric parameters on pneumonitis in patients with stage III non-small cell lung cancer during maintenance treatment with durvalumab after chemoradiotherapy
    Vrankar, M.
    But-Hadzic, J.
    Stanic, K.
    Ciric, E.
    Jelercic, S.
    Vodusek, A. L.
    ANNALS OF ONCOLOGY, 2021, 32 : S944 - S944
  • [26] Adjuvant durvalumab post-chemoradiotherapy in stage III non-small cell lung cancer: experience from the Edinburgh Cancer Centre
    Yan Xiangfei
    Price, Gareth
    Raynes, George
    Stares, Mark
    Evans, Tamasin
    Campbell, Sorcha
    Tufail, Aisha
    MacLennan, Kirsty
    Barrie, Colin
    MacKean, Melanie
    Harrow, Stephen
    Phillips, Iain
    LUNG CANCER, 2022, 165 : S34 - S34
  • [27] Asthma caused by durvalumab after chemoradiotherapy in two patients with non-small cell lung cancer
    Uemura, Takehiro
    Fukumitsu, Kensuke
    Maeno, Ken
    Fukuda, Satoshi
    Onuki, Tomohiro
    Kanemitsu, Yoshihiro
    Oguri, Tetsuya
    Niimi, Akio
    Hida, Toyoaki
    RESPIROLOGY CASE REPORTS, 2021, 9 (09):
  • [28] Influence of durvalumab consolidation on pneumonitis after chemoradiotherapy for unresectable non-small cell lung cancer
    Murata, Saori
    Horinouchi, Hidehito
    Morishita, Momoko
    Kaku, Sawako
    Shinno, Yuki
    Okuma, Yusuke
    Yoshida, Tatsuya
    Goto, Yasushi
    Yamamoto, Noboru
    Okuma, Kae
    Kusumoto, Masahiko
    Ohe, Yuichiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1396 - S1396
  • [29] Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care?
    Chalmers, Anna W.
    Patel, Shiven B.
    Akerley, Wallace
    JOURNAL OF THORACIC DISEASE, 2018, 10 (03) : 1198 - 1200
  • [30] Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer
    Chen, Sheng
    Cheng, Yu-Ling
    Li, Shi-Ting
    Ni, Yao-Jun
    Gu, Biao
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2012, 5 (10) : 823 - 827
12345